FDA Inspection
Lonza Bend Inc.Lonza Bend Inc. – FDA Inspection, Aug 5, 2022
Record Details
This FDA Inspection record concerns Lonza Bend Inc., with an inspection on August 5, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Lonza Bend Inc.
- Inspection Date
- August 5, 2022
- Product Type
- Drugs
View Company Profile
ID · 0945c723-8eb7-470b-91ce-8ec3b2a2456e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1178398
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.192Extent of discrepancy, failure investigations
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lonza Bend Inc.
7| Date | Classification | Office | Project area |
|---|---|---|---|
| May 19, 2026 | Not classified | Seattle District Office | Drug Quality Assurance |
| May 24, 2023 | VAI | Seattle District Office | |
| July 27, 2018 | Not classified | Seattle District Office | |
| July 27, 2018 | Not classified | Seattle District Office | |
| July 21, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Lonza Bend Inc.
- FDA Inspection 1317820 - 2026-05-19
- FDA Inspection 1206164 - 2023-05-24
- FDA Inspection 1065493 - 2018-07-27
- FDA Inspection 1060190 - 2018-07-27
- FDA Inspection 1018924 - 2017-07-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.